{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-004111","form_type":"8-K","ticker":"MCRB","cik":"0001609809","company_name":"Seres Therapeutics, Inc.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.817265+00:00","generated_at":"2026-06-20T17:52:35.340771+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Seres Therapeutics posts corporate presentation at J.P. Morgan Conference; content not fully available","bullets":["Filed updated corporate presentation as Exhibit 99.1 on January 9, 2023.","Presentation dated January 2023 for 41st Annual J.P. Morgan Healthcare Conference.","CEO Eric Shaff featured; specific pipeline or financial details not included in excerpt.","No new material information can be confirmed from the limited exhibit text provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-004111","json":"https://secwatch.observer/filing/0001193125-23-004111.json","markdown":"https://secwatch.observer/filing/0001193125-23-004111.md","text":"https://secwatch.observer/filing/0001193125-23-004111.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1609809/000119312523004111/0001193125-23-004111-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1609809/000119312523004111/d439121d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:52:35.340771+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}